Who We Are
Expertise United: A Decade of Leadership, Trust, and Impactful Solutions
Expertise United: A Decade of Leadership, Trust, and Impactful Solutions
Meet Our Team of Experts
At the heart of our company is a core team of seasoned professionals, each an expert in their respective fields. Our experts have worked together in various configurations for over a decade. During this time, we've successfully held leadership positions across different consulting companies, complementing each other’s strengths and skills to create a well-rounded, cohesive unit.
Together, we form the backbone of a company that thrives on synergy, bringing together complementary expertise and innovation to achieve greater outcomes.
Meet the team – swipe to continue!
Meet Our Team of Scientific Advisors
Meet the team – swipe to continue!
Check Our Services
I am a pharmacist and market access professional with a passion for advancing healthcare solutions. My professional journey began in community pharmacy and the regulatory department of a pharmaceutical company, but I quickly realized that my true calling was in market access.
I started my career as an analyst in a Polish consulting firm, preparing HTA submissions, and later joined Creativ-Ceutical as their first Polish employee. Over the years, I took on a leadership role, growing the Polish office to a team of over 70 talented professionals. Over my 8+ years at Creativ-Ceutical, I progressed from associate to principal consultant, gaining extensive experience across a broad spectrum of market access projects. Building on this solid foundation, I co-founded Assignity (now Clever-Access) where I currently lead Market Access team.
My work focuses on market access strategies throughout product life cycles, evidence generation plans, managed entry agreement evaluations, and the development of value communication strategies including payer value propositions and core value dossiers.
I believe in the „less is more” mindset. I enjoy Pilates, slow Weekend mornings, and reconnecting with nature through cycling, hiking, and stand-up paddleboarding.
Biostatistician by background, I hold a PhD in Health economics.
I joined Creativ-Ceutical for my end-of-studies internship and over 12 years, I
progressively climbed the stairs up to Vice-President of the HEOR group.
I supervised three highly technical departments, including Modelling, Data analytics and Patient-Centered Research departments.
My area of predilection is health economic modelling. I worked 6 years as a Modeller and then led the Modelling team for more than 3 years.
Privately, I do not have major hobbies but an infinity of small ones! With no order of
preference: Knitting, Sewing, Bonsai, Video Edition, Canvas, Video games, crafting fake axes or shield, soap,…
Any new idea is welcome!
Over the last years, I gained significant experience in Strategic Market Access, and Patient-Centered Research in the consulting world, with an in-depth knowledge of payer and HTA requirements. I mostly contribute to European and Global projects, including HTA submission, value communication, strategic positioning, I develop value propositions, value dossiers, dossier submission, landscape assessments, as well as primary research and stakeholders advisory board management. I also have experience in Patient-Centered Research; I recently defended my PhD on the role of health preference information in informing the evaluation of health technologies in France and have significant experience in Discrete Choice Experiment. I work across diverse therapeutic areas, encompassing rare diseases, oncology, dermatology, endocrinology, and more.
Curiosity-driven and adaptable solution-seeker
I have studied Applied Biotechnology and specialized in molecular biology. After completing my studies, I started continuous growth in pharmaceutical consulting, first at a small company and later at Creativ-Ceutical. During my career, I have conducted numerous projects involving landscaping analyses, payer research, funding pathway mapping, reimbursement potential assessment, and pricing. I supported the launch of innovative pharmaceuticals, digital technologies, and integrated care solutions. I was also engaged in the development of new services and tools helping clients to achieve their strategic market access objectives. I am passionate about innovative technology, whether it is used to treat rare diseases, help patients manage themselves, collect evidence in clinical programs, or to make better informed decisions. I am continuously seeking for new solutions to deliver high-standard services that help my clients overcome market access challenges.
After working hours, I like to do sport, mainly go running or biking. For longer breaks, I love outdoor trips into wild nature.
My 16-year career in healthcare consultancies has focused on business strategy development and deployment with an emphasis on Market Access, Health Technology Assessment and Health Economics and Outcomes Research.
I hold a master’s degree in biotechnology engineering, and I began my career in an CRO as an international Business Developer, where I supported clients optimizing their clinical trials. I then spent 11 years with Creativ-Ceutical, a consultancy firm specialised in Market Access and HEOR where I’d the pleasure to meet other Clever-Access’ Co-founders. Starting as the Business Development Director, I later advanced to the role of Vice President of Business Development and Quality Assurance and finally Creativ-Ceutical Co-CEO. As a member of the executive board, I was responsible for the strategic direction and growth of the business.
Throughout my career, I have successfully led and nurtured international multidisciplinary teams within both Clinical Research Organizations (CROs) and consulting environments to support strategic and commercial decisions.
With a keen understanding of client needs, I have proven success in deploying commercially viable solutions to meet the changing demands of the Pharmaceutical and Biotech industry.
Privately, I practice yoga almost every day (thanks to Aurélie), I go for a run as soon as I can, and I love exploring new fields related to nature and music.
I have a statistical background, and PhD in health economics.
After an experience as a biostatistician in a CRO, in 2008, I joined Creativ-Ceutical, another HEOR & Market Access consulting company. Over 14 years, I progressed from baby analyst to Vice-President of the HEOR group, leading several strategic teams such as the Evidence Synthesis and the HTA departments.
I developed specific skills in statistics applied to health and economic analysis, developed HEOR plans, designed dozens of health economic models, managed even more HTA dossiers in multiple countries and enjoyed the coordination of strategic launches for global teams.
I discovered my passion about team management, and happily grew a team of more than 50 talented and professional people.
I also teach health economics in different Universities, master and post-graduate level, where I continue to share my knowledge, and best tips.
Privately, I practice jazz roots dancing, to feed my dynamism and express my improvisational skills, but also Chinese Martial Arts including Kung Fu & Taiji Quan, to work on integration and stability.
I am a mathematician by background, a health economist by experience, and a modeller by passion!
With more than 13 years of experience in economic modelling, I have been responsible for the development of tens of models from scratch, including cost-effectiveness and budget impact models as well as simple cost calculators. My area of expertise spans Markov transition models, discrete event simulations, decision trees and micro-simulations. I have supported many HTA submissions in several countries and have represented pharmaceutical companies in front of HTA bodies. My analytical competence covers several therapeutic areas and diseases, and my professional focus is now directed to economic evaluation of gene therapies. This was a topic of my PhD thesis.
I’m passionate about table tennis, combining fun with a semi-professional edge. Privately, I’m a happy husband and father of two fantastic boys.
Biotechnologist by background, specializing in molecular genetics, and holding a PhD in Clinical Research and Public Health from Aix-Marseille University.
Having always been committed to the scientific world, I embarked on my journey in HEOR a decade ago. My experience spans across several consulting companies, notably Creativ-Ceutical, where I was leading the Evidence Synthesis department. Over the years, I have overseen the development of more than 500 systematic and rapid literature reviews, many of which have supported HTA submissions, including those to NICE.
I am familiar with using various artificial intelligence tools in literature reviews and have been an adviser for several leading companies developing them.
I have shared my expertise through international HEOR/PRMA courses and conferences, including HTA Academy, EMAUD, and ISPOR. As a member of the Cochrane community, I specialize in rapid reviews methodology.
Privately, I love traveling, I am passionate about water sports and psychology.
If you are concerned about your literature review, not sure about the scope and best methodological approach, I am here to support you with my team.
I am passionate about finance and management. I’ve built a foundation in these fields with a master’s degree in accounting and auditing and doctoral studies in Economic Sciences from Krakow University of Economics.
I began my career as an accountant and progressed to finance controller. I developed expertise in diverse areas such as reporting, liquidity management, financial planning, risk assessment, and internal controls. I advanced into various roles within finance and administration. As a manager, I have led departments across medium-sized organizations and global corporations and driven finance transformation initiatives across Europe, including the process migration, design, and implementation of financial tools optimizing operational efficiency. I have engaged directly in mergers and acquisitions, aligning financial strategies with broader organizational goals.
At Clever-Access, I oversee business support; finance, administration, and IT focusing on creating an optimal environment for our operational team to deliver leading services to our clients.
Beyond my professional endeavors, I am passionate about behavioral neuroscience and the psychology of motivation. This interest has inspired me to become a professional coach, enabling me to support individuals in achieving their personal and business aspirations.
When I’m not working, I enjoy listening to and performing music. I also love spending time in nature through hiking and sailing, which rejuvenate my spirit and spark creativity.
I am a biotechnologist with a specialization in medical biotechnology and started my professional adventure in a biotechnological company. However, soon after, I have found my real passion lies in the area of outcomes research.
Over 15 years, I have become an expert in meta-analyses, network meta-analyses, and other types of indirect comparisons. Every day, I try to connect what is disconnected, combine what is scattered, and even make feasible what was considered unfeasible. I have designed, appraised, consulted, and conducted dozens of network meta-analyses and meta-regressions, as well as population-adjusted comparisons, including matching-adjusted indirect comparisons and simulated treatment comparisons.
Privately, I am quite a predictable person: four times I have celebrated the birth of my children and each time it was a son.
I studied mathematics and specialized in financial mathematics and statistics. During my studies, I became interested in HEOR and started working for one of the best Polish companies providing services in this area. Later, I continued my development at Creativ-Ceutical, an international leader in pharmaceutical consulting. Progressing from intern to an experienced consultant working with global companies, I have enjoyed creative work in close cooperation with clients to capture complex natural processes within mathematical models.
During my 10+ years of work in the area, I have gained extensive knowledge and experience to provide comprehensive health economic service. I have worked on many types of models and analyses, as well as their adaptations to specific conditions and countries. Recently, I have been working with passion on dynamic transmission models used in vaccine modelling.
I live in Krakow, Poland, with my husband, our two sons, and a growing family of house plants. My mornings start with coffee and cycling to the office or wherever my legs take me.
I hold a post-graduate degree in Biostatistics (ENSAI, France), an MSc in Health Economics (University of York, UK) and a PhD in Economic Sciences (University of Lyon 1, France). I have worked for 25 years as a consultant in HEOR. Before founding Inovlntell with Pr Toumi, I was Senior Vice-President and Chief Scientific Officer as Creativ-Ceutical, where I managed or directed many health economic and epidemiological research projects including the development of core models, multi-country patient preference studies, network meta-analyses of clinical trials and RWE studies. My expertise lies in the application of quantitative methods in the context of the value assessment of health care interventions. My current focus is on integrating AI in HEOR and market access. I have authored near 100 journal publications in the field of HEOR. I am currently based in the Netherlands and previously worked in the UK and France.
I am a founder of Medicines Development and Training (MDT) services. I am specialist in dermatology (currently Head of Sabouraud Research and Treatment Center for Hair and Skin diseases at Saint-Louis Hospital in Paris), in regulatory science and in HTA for reimbursement purposes with more than 25 years of experience as an expert in clinical and regulatory field. For 12 years I was serving as a Head of Scientific Advice at the French Medicines Agency (ANSM) and was member of several working parties at the EMA). As SAWP Vice-Chair, I was involved in the review of more than 1000 scientific advices in 10 years. In 2010 I joined the Haute Autorité de Santé (HAS), France, as Deputy Director for Health Technology Assessment, and was in charge of European activities related to relative effectiveness assessment, in particular those coordinated by the EUnetHTA, such as early dialogues with developers and methodology of assessment for reimbursement purposes. I also coordinated the SEED (Shaping European Early Dialogues) project financed by European Commission to support early dialogues between developers and HTA bodies as a permanent activity in Europe. Since September 2015 I consult on clinical drug development strategies and act as member of the NDA Advisory Board. My main research areas cover endpoints for marketing authorization/relative effectiveness assessment and bridging of efficacy – effectiveness gap in product development.
Professor of Public Health at Aix-Marseille University.Medical Doctor by training, M.Sc. in Biostatistics Marseille, in Biological Sciences (option respiratory and cardiovascular system) Paris, in pharmacology Marseille and Ph.D. in Economic Sciences Lyon. In 2022, Postgraduate of studies in Artificial Intelligence and Digital Transformation at the Massachusetts Institute of Technology, US.
Global Pharmaceutical Expert with 30+ years of experience in Pricing, Reimbursement, Market Access, Health economics, clinical development and Risk management. After 13 years of collaboration in life sciences consulting, Founder of InovIntell, with the objective to enhance consulting services through extensive use of AI capabilities and digital expertise, combined with mastery of life sciences research.
In 2008-2022, Founder and CEO at Creativ-Ceutical, an international consulting firm dedicated to support health industries and authorities in strategic decision-making. From 2009, Professor at Lyon I University in the Department of Decision Sciences and Health Policies and Director of the Chair of Public Health and Market Access. Initiator and founder of the first European University Diploma of Market Access (EMAUD), now IMAUD (International Market Access Upper Degree), a 5 weeks international course and Initiator and President of the Market Access Society to promote research and scientific activities around market access, public health and health economic
assessment. Editor in Chief of the Journal of Market Access and Health Policy (JMAHP) and also visiting Professor at Beijing University (Third Hospital).In 2003-2008, Global Vice President at Lundbeck A/S. Authored or co-authored more than 400 scientific publications and communications as well as 13 medical and scientific books.